Showing 6591-6600 of 21451 results for "".
- Teoxane Launches Consumer Access to Dermocosmetic Skincare Line in U.S.https://reachmd.com/news/teoxane-launches-consumer-access-to-dermocosmetic-skincare-line-in-us/2475362/Teoxane has announced the U.S. launch of its dermocosmetics line, making its clinically developed skincare products available directly to consumers for the first time through its new online platform, teoxane.us. Previously offered exclusively through aesthetic professionals, the Swiss comp
- Evolving Biomarkers and Assessment Techniques in Critical Care: Enhancing Patient Outcomeshttps://reachmd.com/news/evolving-biomarkers-and-assessment-techniques-in-critical-care-enhancing-patient-outcomes/2474562/Achieving precise fluid management while simultaneously monitoring infection risks and immune dynamics remains a critical challenge in the ICU, spurring the adoption of advanced biomarkers and assessment techniques that are reshaping critical care practice.
- Dietary Patterns and Depression Risk: Gender-Specific Findings in UPF Consumptionhttps://reachmd.com/news/dietary-patterns-and-depression-risk-gender-specific-findings-in-upf-consumption/2474486/In a significant stride toward understanding how diet influences mental health, new research involving more than 15,000 adults has uncovered a compell
- Risk Factors and Treatment Outcomes: Post-Traumatic Osteoarthritis and Hip Arthroplastyhttps://reachmd.com/news/risk-factors-and-treatment-outcomes-post-traumatic-osteoarthritis-and-hip-arthroplasty/2474473/For patients suffering traumatic acetabular fractures, the journey to restored mobility and relief from pain can be complex and protracted. What begins as a high-energy injury often progresses to post-
- Conversion Therapy and Cardiovascular Risk in Young Adultshttps://reachmd.com/news/conversion-therapy-and-cardiovascular-risk-in-young-adults/2474528/Recent research uncovers a significant link between conversion therapy and increased cardiovascular risk in young adults assigned male at birth, noting blood pressure readings 3 to 5 points higher in those who experienced the discredited practice.
- Smoking Cessation and Hidradenitis Suppurativa: Evaluating Risk Reductionhttps://reachmd.com/news/smoking-cessation-and-hidradenitis-suppurativa-evaluating-risk-reduction/2474527/Recent studies indicate that smoking cessation is crucial in significantly lowering the risk of developing hidradenitis suppurativa. This finding underscores the need for patients to commit to smoke-free lifestyles for enhanced skin health.
- AI and Delirium: Enhancing Prediction and Treatment in Hospital Carehttps://reachmd.com/news/ai-and-delirium-enhancing-prediction-and-treatment-in-hospital-care/2474525/Artificial intelligence is revolutionizing hospital care by refining the detection and treatment of delirium. Recent clinical applications demonstrate a fourfold increase in detection rates and the capability for timely, individualized interventions that significantly impro
- Low-Dose Rapamycin: Assessing Healthspan Enhancement in Older Adultshttps://reachmd.com/news/low-dose-rapamycin-assessing-healthspan-enhancement-in-older-adults/2474526/Insights from the PEARL trial have reignited scientific interest in low-dose rapamycin as a strategy to extend healthspan in older adults. This article explores key findings from the trial, which demonstrate that weekly rapamycin is well-tolerated and may yield mod
- CBCT-to-CT Synthesis: A Hybrid Approach Using CycleGAN and Latent Diffusionhttps://reachmd.com/news/cbct-to-ct-synthesis-a-hybrid-approach-using-cyclegan-and-latent-diffusion/2474538/Recent innovations in AI-driven medical imaging have given rise to a powerful hybrid framework that combines CycleGAN and latent diffusion models to synthesize high-fidelity CT images from CBCT data. This methodology addresses long-standing limitations of CBCT imag
- Corticosteroids and Their Role in Managing Non-Viral Community-Acquired Pneumoniahttps://reachmd.com/news/corticosteroids-and-their-role-in-managing-non-viral-community-acquired-pneumonia/2474536/New insights from rigorous trials and meta-analyses reveal that corticosteroids—particularly hydrocortisone—play a significant role in reducing inflammation and mortality in adults with severe non-viral community-acquired pneumonia (CAP). These findings are shiftin